Pmu14 - Comparison to Standard of Care: Modelisation of Potential Selection Bias for Active Reference in Randomised Clinical Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1850
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

How to Spot Bias and Other Potential Problems in Randomised Controlled Trials

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2004English

Failure to Address Potential Bias in Non-Randomised Controlled Clinical Trials May Cause Lack of Evidence on Patient-Reported Outcomes: A Method Study

BMJ Open
Medicine
2014English

Prospective Registration, Bias Risk and Outcome-Reporting Bias in Randomised Clinical Trials of Traditional Chinese Medicine: An Empirical Methodological Study

BMJ Open
Medicine
2013English

Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children: TABLE 1

Pediatrics
Child HealthPediatricsPerinatology
2012English

Table 3: Risk of Bias Assessment (N = 24 Trials) (Cochrane Risk of Bias Tool for Randomised Trials (Higgins Et Al. 2011)).

English

Randomised Clinical Trials in General Practice.

BMJ
1992English

Patients’ Preferences for Selection of Endpoints in Cardiovascular Clinical Trials

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2014English

Empirical Evidence for Outcome Reporting Bias in Randomized Clinical Trials of Acupuncture: Comparison of Registered Records and Subsequent Publications

Trials
MedicinePharmacology
2015English

Development of Standard Clinical Endpoints for Use in Dengue Interventional Trials

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy